The cost of accessing infant HIV medications and health services in Uganda
The cost of accessing infant HIV medications and health services in Uganda
复制标题
DOI：
10.1080/09540121.2017.1330531
复制
发表时间：
2017-01-01
影响因子：
1.7
通讯作者：
Stockman, Jamila K.
中科院分区：
文献类型：
--
作者：
Bergmann, Julie N.;Wanyenze, Rhoda K.;Stockman, Jamila K.
患者费用是消除艾滋病毒母婴传播的关键障碍。尽管乌干达政府提供免费的艾滋病毒公共服务，但婴儿抗逆转录病毒（ARV）预防覆盖率仍然很低（25%）。为了了解母亲为其婴儿获得抗逆转录病毒药物预防所产生的成本，我们进行了一项混合方法研究，以量化和确定其直接成本。我们使用了来自乌干达49名艾滋病毒阳性母亲的横断面调查数据和焦点小组讨论。计算了获得婴儿艾滋病毒服务所涉及的直接成本（例如交通、看护、服务/药物）的平均值和标准差。参加艾滋病毒诊所就诊的直接费用平均为3.71美元（SD= 3.52美元）。焦点小组讨论确定了阻碍获得婴儿艾滋病毒服务的两项费用：运输费用和非正式服务费。所有参与者都报告了与获得婴儿艾滋病毒服务相关的重大费用-相当于2-3天的收入。为了解决运输成本问题，应该探索社区和家庭护理模式。此外，应实施更严格的政策和监督，以防止非正式的艾滋病毒服务收费。
Patient costs are a critical barrier to the elimination of mother to child HIV transmission. Despite the Ugandan government providing free public HIV services, infant antiretroviral (ARV) prophylaxis coverage remains low (25%). To understand costs mothers incur in accessing ARV prophylaxis for their infants, we conducted a mixed methods study to quantify and identify their direct costs. We used cross-sectional survey data and focus group discussions from 49 HIV-positive mothers in Uganda. Means and standard deviations were calculated for the direct costs (e.g., transportation, caretaker, services/medications) involved in accessing infant HIV services. The direct cost of attending HIV clinic visits averaged $3.71 (SD=$3.52). Focus group discussions identified two costs hindering access to infant HIV services: transportation costs and informal service charges. All participants reported significant costs associated with accessing infant HIV services - the equivalent of 2-3 days' income. To address transportation costs, community and home care models should be explored. Additionally, stricter policies and oversight should be implemented to prevent informal HIV service charges.